EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Insuficiencia regulatoria de productos herbolarios en México: análisis crítico basado en alertas sanitarias emitidas por COFEPRIS

Brian Enrique Rocha Maya, Antonio Juárez Calixto, Arturo Vázquez Silva, Suset Jannette Tolentino Hernández

Latin american journal of clinical sciences and medical technology · 27.05.2026 · 8 (1) · 64-75

DOI: 10.34141/ljcs7866590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, erschienen am 27.05.2026. Verfasst von Brian Enrique Rocha Maya und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herbal products occupy a significant position in the Mexican market; however, their regulation presents gaps that compromise consumer safety and public health. This article provides a critical perspective on the regulatory framework applicable to these products, highlighting inconsistencies in legal definitions, the absence of specific technical guidelines, and limitations in sanitary surveillance and pharmacovigilance. An analysis of health alerts issued by Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) reveals recurring patterns of adulteration, alteration, and misleading advertising, thereby evidencing structural weaknesses in regulatory control. Among the most relevant gaps is the lack of mandatory analytical methods for evaluating finished products, which hinders the timely detection of risks and limits the capacity for preventive oversight. Regulatory and technical strategies are proposed, including developing specific legislation, standardizing analytical methods, strengthening pharmacovigilance systems, and implementing traceability mechanisms, all aimed at improving the quality and safety of herbal products in Mexico. The adoption of these measures would facilitate the transition toward a more coherent, preventive, and internationally aligned regulatory system.

Zitieren

APA

Maya, B. E. R., Calixto, A. J., Silva, A. V., & Hernández, S. J. T. (2026). Insuficiencia regulatoria de productos herbolarios en México: análisis crítico basado en alertas sanitarias emitidas por COFEPRIS. Latin american journal of clinical sciences and medical technology, 8(1), 64-75. https://doi.org/10.34141/ljcs7866590

Vancouver

Maya BER, Calixto AJ, Silva AV, Hernández SJT. Insuficiencia regulatoria de productos herbolarios en México: análisis crítico basado en alertas sanitarias emitidas por COFEPRIS. Latin american journal of clinical sciences and medical technology. 2026;8(1):64-75. doi:10.34141/ljcs7866590

BibTeX
@article{Maya2026,
  author = {Maya, Brian Enrique Rocha and Calixto, Antonio Juárez and Silva, Arturo Vázquez and Hernández, Suset Jannette Tolentino},
  title = {Insuficiencia regulatoria de productos herbolarios en México: análisis crítico basado en alertas sanitarias emitidas por COFEPRIS},
  journal = {Latin american journal of clinical sciences and medical technology},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {64--75},
  doi = {10.34141/ljcs7866590}
}
Kostenlos starten →